Literature DB >> 3371577

Pattern of myelinated fibre loss in the sural nerve in neuropathy related to type 1 (insulin-dependent) diabetes.

J G Llewelyn1, P K Thomas, S G Gilbey, P J Watkins, J R Muddle.   

Abstract

Sural nerve biopsies were obtained from 17 diabetic patients with neuropathy. All patients except three had both a symmetric distal sensory and autonomic polyneuropathy related to Type 1 (insulin-dependent) diabetes mellitus; 3 patients had a purely sensory polyneuropathy. Mean age was 34.5 years (range 18-53 years). The biopsies were compared with specimens from an age-matched control series. Myelinated fibre loss in the diabetic nerves was found to be nonuniform. Although patchy fibre loss has been considered to favour a vascular basis, an identical pattern of nonuniform loss was observed in a series of sural nerve biopsies from patients with Type I hereditary motor and sensory neuropathy, a subgroup within the spectrum of peroneal muscular atrophy, mainly of autosomal dominant inheritance, and a condition in which a vascular causation can be discounted. Possible reasons for nonuniform fibre loss other than vascular disease are discussed.

Entities:  

Mesh:

Year:  1988        PMID: 3371577     DOI: 10.1007/bf00276850

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  32 in total

1.  Basic two-dye stains for epoxy-embedded 0.3-1 sections.

Authors:  J Sievers
Journal:  Stain Technol       Date:  1971-07

2.  Peripheral neuropathy in chronic disease of the respiratory tract.

Authors:  O Appenzeller; R D Parks; J MacGee
Journal:  Am J Med       Date:  1968-06       Impact factor: 4.965

3.  The topography of root fibres within the sciatic nerve trunk of the dog.

Authors:  T Ueyama
Journal:  J Anat       Date:  1978-10       Impact factor: 2.610

4.  Small vessel disease in progressive diabetic neuropathy associated with good metabolic control.

Authors:  W R Timperley; A J Boulton; G A Davies-Jones; J A Jarratt; J D Ward
Journal:  J Clin Pathol       Date:  1985-09       Impact factor: 3.411

5.  Polyol pathway activity and myo-inositol metabolism. A suggested relationship in the pathogenesis of diabetic neuropathy.

Authors:  D Finegold; S A Lattimer; S Nolle; M Bernstein; D A Greene
Journal:  Diabetes       Date:  1983-11       Impact factor: 9.461

6.  Altered axonal transport of cytoskeletal proteins in the mutant diabetic mouse.

Authors:  M Vitadello; G Filliatreau; J L Dupont; R Hassig; A Gorio; L Di Giamberardino
Journal:  J Neurochem       Date:  1985-09       Impact factor: 5.372

7.  [Incidence of polyneuropathies in chronic obstructive bronchopneumopathies].

Authors:  B Paramelle; A Vila; P Pollak; P Muller; D Gavelle; F Reymond; C Brambilla; P Stoebner
Journal:  Presse Med       Date:  1986-03-22       Impact factor: 1.228

8.  Decreased axonal transport of structural proteins in streptozotocin diabetic rats.

Authors:  J Jakobsen; P Sidenius
Journal:  J Clin Invest       Date:  1980-08       Impact factor: 14.808

9.  The clinical features of hereditary motor and sensory neuropathy types I and II.

Authors:  A E Harding; P K Thomas
Journal:  Brain       Date:  1980-06       Impact factor: 13.501

10.  Impaired rat sciatic nerve sodium-potassium adenosine triphosphatase in acute streptozocin diabetes and its correction by dietary myo-inositol supplementation.

Authors:  D A Greene; S A Lattimer
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

View more
  10 in total

1.  Endoneurial capillary abnormalities in mild human diabetic neuropathy.

Authors:  R A Malik; A Veves; E A Masson; A K Sharma; A K Ah-See; W Schady; R H Lye; A J Boulton
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-07       Impact factor: 10.154

Review 2.  Neurology.

Authors:  A N Gale; J M Gibbs; A H Schapira; P K Thomas
Journal:  Postgrad Med J       Date:  1991-06       Impact factor: 2.401

Review 3.  Aldose reductase inhibitors in the treatment of diabetic neuropathy. A review of the rationale and clinical evidence.

Authors:  E A Masson; A J Boulton
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

4.  Comparison of the effects of ascorbyl gamma-linolenic acid and gamma-linolenic acid in the correction of neurovascular deficits in diabetic rats.

Authors:  N E Cameron; M A Cotter
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

Review 5.  The role of glycation in the pathogenesis of diabetic polyneuropathy.

Authors:  R H King
Journal:  Mol Pathol       Date:  2001-12

6.  Morphometry of endoneurial capillaries in diabetic sensory and autonomic neuropathy.

Authors:  J Bradley; P K Thomas; R H King; J G Llewelyn; J R Muddle; P J Watkins
Journal:  Diabetologia       Date:  1990-10       Impact factor: 10.122

7.  Angiotensin II receptor blockade improves nerve function, modulates nerve blood flow and stimulates endoneurial angiogenesis in streptozotocin-diabetic rats and nerve function.

Authors:  E K Maxfield; N E Cameron; M A Cotter; K C Dines
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

8.  Use of ion channel blockers in the exploration of possible mechanisms involved in the myopathy of diabetic mice.

Authors:  S Y Lin-Shiau; S H Liu; M J Lin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-09       Impact factor: 3.000

9.  Microangiopathy in human diabetic neuropathy: relationship between capillary abnormalities and the severity of neuropathy.

Authors:  R A Malik; P G Newrick; A K Sharma; A Jennings; A K Ah-See; T M Mayhew; J Jakubowski; A J Boulton; J D Ward
Journal:  Diabetologia       Date:  1989-02       Impact factor: 10.122

Review 10.  Mechanism of diabetic neuropathy: Where are we now and where to go?

Authors:  Soroku Yagihashi; Hiroki Mizukami; Kazuhiro Sugimoto
Journal:  J Diabetes Investig       Date:  2011-01-24       Impact factor: 4.232

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.